This program has helped finance research projects developed by the Group IDIVAL Infection and Immunity and Digestive Pathology

The results of this Group in 2015 have been highlighting notable scientific production of more than 100 points of impact and funding from the Health Institute Carlos III, which exceeds € 600,000 for the development of an integrated project of excellence that I begin in 2016, focusing on the study of hepatitis C with the participation of half a dozen researchers responsible for IDIVAL Groups

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Theriva™ Biologics to Present Preclini...

by Theriva™ Biologics

Theriva™ Biologics has announced the presentation of preclinical da...

Photos Stream